(Total Views: 685)
Posted On: 07/19/2024 11:38:19 AM
Post# of 148862
Seems FDA nixed Agenus' plan for accelerated approval for botensilimab/balstilimab in MSS colorectal cancer.
https://www.fiercebiotech.com/biotech/fda-wre...ombination
https://www.fiercebiotech.com/biotech/fda-wre...ombination
(3)
(0)Scroll down for more posts ▼
